The Role of Mitokines in Diabetic Nephropathy

Ming Yang; Wei Chen; Liyu He; Xi Wang; Di Liu; Li Xiao; Lin Sun

doi:10.2174/0109298673255403230919061828

The Role of Mitokines in Diabetic Nephropathy

Curr Med Chem. 2023 Oct 26. doi: 10.2174/0109298673255403230919061828. Online ahead of print.

Authors

Ming Yang¹, Wei Chen¹, Liyu He¹, Xi Wang², Di Liu¹, Li Xiao¹, Lin Sun¹

Affiliations

¹ Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.
² Department of Nutrition, Xiangya Hospital, Central South University, Changsha, Hunan, China.

PMID: 37921178
DOI: 10.2174/0109298673255403230919061828

Abstract

Diabetic nephropathy (DN) has gradually become one of the main causes of end-stage renal disease (ESRD). However, there is still a lack of effective preventive measures to delay its progression. As the energy factory in the cell, mitochondria play an irreplaceable role in maintaining cell homeostasis. Interestingly, recent studies have shown that in addition to maintaining homeostasis in cells in which mitochondria reside, when mitochondrial perturbations occur in one tissue, distal tissues can also sense and act through mitochondrial stress response pathways through a group of proteins or peptides called "mitokines". Here, we reviewed the mitokines that have been found thus far and summarized their research progress in DN. Finally, we explored the possibility of mitokines as potential therapeutic targets for DN.

Keywords: Diabetic nephropathy (DN); FGF21; Humanin; MOTS-c; Mitokines; mitochondrial stress ?.